Zobrazeno 1 - 10
of 164
pro vyhledávání: '"Xiang-Yuan Wu"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/1d2293a7401d491eb46c815a459dc167
Autor:
Xing Li, Jie Chen, Yong-Jian Chen, Yi-Dan Qiao, Li-Yun Zhao, Nan Jiang, Xiang-Yuan Wu, Yan-Fang Xing
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-12 (2021)
Li et al. show that dexamethasone and lactoferrin induced polymorphonuclear myeloid-derived suppressor cells relieve inflammatory conditions in mouse models with minimal effect on tumour growth. This work demonstrates promise for combating inflammato
Externí odkaz:
https://doaj.org/article/a5f0da4bd4164d039b55198c4e4188a9
Autor:
Zhan-Hong Chen, Jing-Jing Qi, Qi-Nian Wu, Jia-Huan Lu, Ze-Xian Liu, Yun Wang, Pei-Shan Hu, Ting Li, Jin-Fei Lin, Xiang-Yuan Wu, Lei Miao, Zhao-Lei Zeng, Dan Xie, Huai-Qiang Ju, Rui-Hua Xu, Feng Wang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-18 (2019)
Abstract Background Deregulation of protein translation control is a hallmark of cancers. Eukaryotic initiation factor 4A2 (EIF4A2) is required for mRNA binding to ribosome and plays an important role in translation initiation. However, little is kno
Externí odkaz:
https://doaj.org/article/4898116ca4344a52a40623baf9ce1d26
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Blood-based tumor mutational burden (bTMB) was recently found to be suboptimal in predicting overall survival (OS) benefits of atezolizumab over docetaxel among patients with advanced non-small cell lung cancer (NSCLC). The maximum somati
Externí odkaz:
https://doaj.org/article/10a4cd5a57f040d79516e31d540b2b71
Autor:
Chang-Chang Jia, Tian-Tian Wang, Wei Liu, Bin-Sheng Fu, XueFeng Hua, Guo-Ying Wang, Tuan-Jie Li, Xing Li, Xiang-Yuan Wu, Yan Tai, Jie Zhou, Gui-Hua Chen, Qi Zhang
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63243 (2013)
Cancer-associated fibroblasts (CAFs) are reported to support tumorigenesis by stimulating angiogenesis, cancer cell proliferation, and invasion in most solid tumors. However, the roles of CAFs in the liver cancer microenvironment have not been thorou
Externí odkaz:
https://doaj.org/article/e0c83813936842a29e4492e0f6b44b13
Autor:
Tian-Tian Wang, Qing-Hua Cao, Ming-Yuan Chen, Qing Xia, Xin-Juan Fan, Xiao-Kun Ma, Qu Lin, Chang-Chang Jia, Min Dong, Dan-Yun Ruan, Ze-Xiao Lin, Jing-Yun Wen, Li Wei, Xing Li, Zhan-Hong Chen, Lei Wang, Xiang-Yuan Wu, Xiang-Bo Wan
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e80317 (2013)
Autophagy can be tumor suppressive as well as promotive in regulation of tumorigenesis and disease progression. Accordingly, the prognostic significance of autophagy key regulator Beclin 1 was varied among different tumors. Here, we detected the clin
Externí odkaz:
https://doaj.org/article/adc78059c4f140c09588ea933c85aa77
Autor:
Xiang-Bo Wan, Yan Zhao, Xin-Juan Fan, Hong-Min Cai, Yan Zhang, Ming-Yuan Chen, Jie Xu, Xiang-Yuan Wu, Hong-Bo Li, Yi-Xin Zeng, Ming-Huang Hong, Quentin Liu
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e31989 (2012)
BACKGROUND:Accurate prognostication of locally advanced nasopharyngeal carcinoma (NPC) will benefit patients for tailored therapy. Here, we addressed this issue by developing a mathematical algorithm based on support vector machine (SVM) through inte
Externí odkaz:
https://doaj.org/article/cac1826dd0ba444db61a9b616f7bc7f2
Autor:
Rui-Hua Xu, Yu-Hong Li, Feng-Hua Wang, Dong-Sheng Zhang, Hui-Yan Luo, Shuang-Zhen Chen, Si-Mei Shi, Ying Guo, Hong Qiu, Zhi-Qiang Wang, Zong-Jiong Mai, Ying Jin, Xiang-Yuan Wu, Zeng-Qing Guo, Qing-Feng Zou, Ying Yuan, Jie-Er Ying, Fu-Xiang Zhou, Zhi-Xiang Zhuang, Yi-Chen Yao, Zhi-Gang Ma, Xiao-Hua Hu, Wei Wang, Yan Zhang, Wei-Jia Fang, Xiang-Lin Yuan, Yan-Qiao Zhang, Jian Xiao, Ming-Ming He, Feng Wang
Supplementary Figure from A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b06772fe70faec5ac401fdfce8e7dbf
https://doi.org/10.1158/1078-0432.22488381.v1
https://doi.org/10.1158/1078-0432.22488381.v1
Autor:
Rui-Hua Xu, Yu-Hong Li, Feng-Hua Wang, Dong-Sheng Zhang, Hui-Yan Luo, Shuang-Zhen Chen, Si-Mei Shi, Ying Guo, Hong Qiu, Zhi-Qiang Wang, Zong-Jiong Mai, Ying Jin, Xiang-Yuan Wu, Zeng-Qing Guo, Qing-Feng Zou, Ying Yuan, Jie-Er Ying, Fu-Xiang Zhou, Zhi-Xiang Zhuang, Yi-Chen Yao, Zhi-Gang Ma, Xiao-Hua Hu, Wei Wang, Yan Zhang, Wei-Jia Fang, Xiang-Lin Yuan, Yan-Qiao Zhang, Jian Xiao, Ming-Ming He, Feng Wang
Supplementary Data from A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ddb2013da603b76379f8a09fb0d76e8
https://doi.org/10.1158/1078-0432.22488387.v1
https://doi.org/10.1158/1078-0432.22488387.v1
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Targeted therapy based on pathway analysis of hepatitis B-related hepatocellular carcinoma (HCC) may be a promising remedy. CASE SUMMARY The present case involved an advanced hepatocellular carcinoma (HCC) patient who did not receive local